Kolexia
Dubois Bruno Neurologie
Dubois Bruno
Neurologie
Hôpital Pitie Salpetriere
Paris, France
644 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie d'Alzheimer Démence Démence frontotemporale Atrophie Symptômes prodromiques Troubles de la mémoire Dégénérescence lobaire frontotemporale Aphasie Aphasie progressive primaire

Collaborateurs

Voir plus
Habert Marie-Odile
Habert Marie-Odile
Hôpital Pitie Salpetriere, Paris, France
Epelbaum Stephane
Epelbaum Stephane
Hôpital Pitie Salpetriere, Paris, France
Pasquier-Garguillo Florence
Pasquier-Garguillo Florence
Hôpital Roger Salengro, Lille, France
Sarazin Marie
Sarazin Marie
Centre hospitalier Sainte-Anne, Paris, France

Industries

Voir plus
Biogen
19 collaboration(s)
Dernière en 2022
Wedo studios
6 collaboration(s)
Dernière en 2021
Roche
6 collaboration(s)
Dernière en 2021
QYNAPSE
6 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
The association between posterior resting-state EEG alpha rhythms and functional MRI connectivity in older adults with subjective memory complaint.
Neurobiology of aging   28 février 2024
The Memory Binding Test Detects Early Subtle Episodic Memory Decline in Preclinical Alzheimer's Disease: A Longitudinal Study.
Journal of Alzheimer's disease : JAD   22 février 2024
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders.
The Lancet. Neurology   19 février 2024
STIM-SD: Investigation of the Therapeutic Value of Transcranial Stimulation With Direct Current on Language Disorders in Semantic Dementia
Essai Clinique (Assistance publique – Hôpitaux de Paris)   16 janvier 2024
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study.
Alzheimer's research & therapy   02 novembre 2023
The dual-path hypothesis for the emergence of anosognosia in Alzheimer's disease.
Frontiers in neurology   02 novembre 2023
Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment.
Alzheimer's research & therapy   14 octobre 2023
Biomarkers in Alzheimer's disease: role in early and differential diagnosis and recognition of atypical variants.
Alzheimer's research & therapy   13 octobre 2023
DIAN-TU: A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
Essai Clinique (Washington University School of Medicine)   06 octobre 2023
Masitinib in Patients With Mild to Moderate Alzheimer's Disease: A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Phase 3 Study to Evaluate the Safety and Efficacy of Masitinib in Patients With Mild to Moderate Alzheimer's Disease
Essai Clinique (AB Science)   27 septembre 2023